An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke

Author:

Fang Zongping1ORCID,Wu Di2ORCID,Deng Jiao1ORCID,Yang Qianzi1,Zhang Xijing1,Chen Jian2,Wang Shiquan1,Hu Sijun3,Hou Wugang1,Ning Siming3,Ding Yi4ORCID,Fan Zhongmin1,Jiang Zhenhua1,Kang Junjun5,Liu Yingying5ORCID,Miao Jinlin6,Ji Xunming2ORCID,Dong Hailong1ORCID,Xiong Lize17ORCID

Affiliation:

1. Department of Anesthesiology and Perioperative Medicine and Department of Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China.

2. Department of neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Beijing Institute of Brain Disorders, Capital Medical University, Beijing 10053, China.

3. State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

4. Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

5. Department of Neurobiology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

6. National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi’an, Shaanxi 710032, China.

7. Translational Research Institute of Brain and Brain-Like Intelligence and Department of Anesthesiology and Perioperative Medicine, Shanghai Fourth People’s Hospital, Tongji University School of Medicine, Shanghai 200434, China.

Abstract

Tat-CIRP perturbed the function of MD2 and provided robust neuroprotection in cells, rodents, and gyrencephalic nonhuman primates.

Funder

Innovative Research Group Project of the National Natural Science Foundation of China

National Key Research and Development Program of China Stem Cell and Translational Research

the Major Program of National Natural Science Foundation of China

International Cooperation and Exchange of the National Natural Science Foundation of China

the National Natural Science Foundation of China Youth Fund

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3